Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Glipizide 5mg tablets
0601021P0AAABAB
|
Glipizide | Glipizide | Endocrine System | 4,084 |
|
Minodiab 5mg tablets
0601021P0BCADAB
|
Minodiab | Glipizide | Endocrine System | 93 |
|
Glipizide 2.5mg tablets
0601021P0AAAAAA
|
Glipizide | Glipizide | Endocrine System | 1 |
|
Glibenese 5mg tablets
0601021P0BBAAAB
|
Glibenese | Glipizide | Endocrine System | No data available |
|
Minodiab 2.5mg tablets
0601021P0BCACAA
|
Minodiab | Glipizide | Endocrine System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.